This article was originally published in The Tan Sheet
House Government Reform Committee Chairman Tom Davis (R-Va.) will introduce a bill the week of May 23 proposing a uniform drug testing policy for major professional sports leagues, including MLB, the NFL and the NBA. Co-authored by Rep. Henry Waxman (D-Calif.) and Sen. John McCain (R-Ariz.), the legislation likely will suggest similar penalties to Rep. Cliff Stearns' (R-Fla.) Drug Free Sports Act, which calls for minimum two-year bans for first offenses and lifetime bans for second offenses. The House Government Reform Committee held a hearing on the NBA's drug policy on the heels of an NFL meeting in April (1"The Tan Sheet" May 2, 2005, p. 14)...
You may also be interested in...
The absence of dietary supplement good manufacturing practices has had minimal impact on the National Football League's steroid policy, according to Commissioner Paul Tagliabue
Formycon’s CEO has offered the latest indication that the coronavirus outbreak could provide a tailwind for biosimilars, as the firm gave an update on its biosimilars pipeline – including ranibizumab, ustekinumab, aflibercept and an undisclosed molecule, as well as other unrevealed projects – and how it has been affected by the pandemic.
With the formal, virtual kick-off meeting set for 23 July, US FDA and sponsors are looking at a transformed landscape as they discuss what the next five years of user fees will look like.